
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Matthew Kurtz, Regional Sales Manager
T: (212) 951-6751
F: (212) 951-6604
Covers New York, New Jersey, and international outside Canada






